A Multicenter Study of RUS NE

This sponsor-initiated, randomized controlled clinical trial aims to demonstrate the clinical efficacy of RUS NE Surgical Navigation System in patients undergoing robotic-assisted partial nephrectomy. The trial will compare the experimental group (n=102) using RUS NE with a control group (n=102), aiming to show an 10% reduction in operation time. The study will involve 6 medical centers in South Korea in patient recruitment and evaluate the clinical efficacy and feasibility of the software, which has been shown to be reliable in previous studies. * Investigational Medical Device: RUS NE (Endoscopic Imaging Treatment Planning Software) * Clinical Trial duration: 24 months from IRB approval -Target number of subjects: Total of 204 participants

NCT Number	NCT06868186
Lead Sponsor	Hutom Corp Collaborators: Asan Medical Center, Seoul National University Hospital, Samsung Medical Center, Chonnam National University Hospital, Kyungpook National University Hospital, Severance Hospital
Conditions	Renal Tumors
Enrollment	204 participants
Start Date	2025-04-29
Primary Completion	2025-08-29 (estimated)
Study Completion	2026-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-11